Mechanisms involved in the therapeutic effects of soybean (glycine max)

International Journal of Food Properties

Volumn 17, Issue 6, 2014, Pages 1332-1354

  Ahmad, Asif ^a   Hayat, Imran ^b   Arif, Sara ^a   Masud, Tariq ^a   Khalid, Nauman ^c   Ahmed, Anwaar ^a  

^a PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

^b The University of Poonch   (Pakistan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Health benefits; Isoflavones; Mechanisms; Proteins; Soybeans

Indexed keywords

AMINO ACIDS; BIOACTIVITY; DISEASES; FLAVONOIDS; HEALTH; MECHANISMS; PROTEINS;

BIOLOGICALLY ACTIVE COMPOUNDS; CARDIO-VASCULAR DISEASE; DIFFERENT MECHANISMS; FUNCTIONAL INGREDIENT; HEALTH BENEFITS; ISOFLAVONES; NEURODEGENERATIVE DISORDERS; SOYBEANS;

NITROGEN FIXATION;

EID: 84896324381     PISSN: 10942912     EISSN: 15322386     Source Type: Journal    
DOI: 10.1080/10942912.2012.714828     Document Type: Review

References (182)

1. Ren, H., Liu, H., Endo, H., Takagi, Y., and, Hayashi, T. 2006. Antimutagenic and anti-oxidative activities found in Chinese traditional soybean fermented products furu. Food Chemistry, 95: 71-76.
2. Hamada, G.S., Kowalski, L.P., Nishmoto, I.N., Rodrigues, J.J.G., Riya, K., Sasuki, S., Hanaoka, T., Tsugane, S., and, Asai, M. 2002. Risk factors for stomach cancer in Brazil (II): A case-control study among Japanese Brazilians in Sao Paulo. Japanese Journal of Clinical Oncology, 32: 284-290.
3. Kim, L.S., Berhow, M.A., Kim, J.T., Chi, H.Y., Lee, S.J., and, Chung, I.M. 2006. Evaluation of soyasaponin, isoflavone, protein, lipid, and free sugar accumulation in developing soybean seeds. Journal of Agriculture and Food Chemistry, 54: 10003-10010.
4. Hou, H.J., and, Chang, C.K. 2004. Structural characteristics of purified β-conglycinin from soybeans stored under four conditions. Journal of Agriculture and Food Chemistry, 52 (26): 7931-7937.
5. Young, V.R. 1991. Soy protein in relation to human protein and amino acid nutrition. Dietary Association, 91: 828-235.
6. Karr-Lilienthal, L.K., Kadzere, C.T., Grieshop, C.M., and, Fahey, G.C. 2005. Chemical and nutritional properties of soybean carbohydrates as related to nonruminants. Livestock Production Science, 97: 1-12.
7. Ellington, A.A., Berhow, M., and, Singletary, K.W. 2005. Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins. Carcinogenesis, 26 (1): 159-167.
8. Careri, M., Elviri, L., and, Mangia, A. 2001. Liquid chromatography-UV determination and liquid chromatography-atmospheric pressure chemical ionization mass spectrometric characterization of sitosterol and stigmasterol in soybean oil. Journal of Chromatography, 935: 249-257.
9. Rozner, S., and, Garti, N. 2006. The activity and absorption relationship of cholesterol and phytosterols. Colloids and surfaces. Physicochemical and Engineering Aspects, 283: 435-456.
10. Kim, E.H., Ro, H.M., Kim, S.L., Kim, H.S., and, Chung, I.M. 2012. Analysis of isoflavone, phenolic, soyasapogenol, and tocopherol compounds in soybean [Glycine max (L.). Merrill] germplasms of different seed weights and origins. Journal of Agriculture and Food Chemistry, 60: 6045-6055.
11. Kao, T.H., and, Chen, B.H. 2006. Functional components in soybean cake and their effects on antioxidant activity. Journal of Agriculture and Food Chemistry, 54: 7544-7555.
12. Kao, T.H., Lu, Y.F., and, Chen, B.H. 2005. Preparative chromatography of four groups of isoflavones from soybean cake. European Food Research and Technology, 221: 459-465.
13. Izumi, T., Piskula, M.K., Osawa, S., Obata, A., Tobe, K., Saito, M., Kataoka, S., Kubota, Y., and, Kikuchi, M. 2000. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. Journal of Nutrition, 130: 1695-1699.
14. Wang, H., and, Murphy, P. 1994. Isoflavone content in commercial soybean foods. Journal of Agriculture and Food Chemistry, 42: 1666-1674.
15. Hodgson, J.M., Croft, K.D., Puddey, I.B., Mori, T.A., and, Beilin, L.J. 1996. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. Journal of Nutrition and Biochemistry, 7: 664-669.
16. Cheng, Y.Q., Zhu, Y.P., Hu, Q., Li, L.T., Saito, M., Zhang, S.X., and, Yin, L.J. 2011. Transformation of isoflavones during sufu (a traditional Chinese fermented soybean curd) production by fermentation with mucor flavus at low temperature. International Journal of Food Properties, 14: 629-639.
17. Chun, J., Kim, G.M., and, Lee, K.W. 2007. Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic aci bacteria. Journal of Food Science, 72: 39-44.
18. Tang, A.L., Shah, N.P., Wilcox, G., Walker, K.Z., and, Stojanovska, L. 2007. Fermentation of calcium-fortified soymilk with Lactobacillus: Effects on calcium solubility, isoflavone conversion, and production of organic acids. Journal of Food Science, 72: 431-436.
19. Wang, L.J., Li, D., Zou, L., Dong, C.X., Cheng, Y.Q., Yamaki, K., and, Li, L.T. 2007. Antioxidative activity of Douchi (A Chinese traditional salt-fermented soybean food) extracts during its processing. International Journal of Food Properties, 10: 385-396.
20. Khan, N., Adhami, V.M., and, Mukhtar, H. 2010. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocrine-Related Cancer, 17: 39-52.
21. Gladysheva, I.P., Moroz, N.A., Karmakova, T.A., Nemtsova, E.R., Yakubovskaya, R.I., and, Larionova, N.I. 2001. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents. Journal of Drug and Targeting, 9 (5): 303-316.
22. Minemoto, Y., Fang, X., Hakamata, K., Watanabe, Y., Adachi, S., Kometani, T., and, Matsuno, R. 2002. Oxidation of linoleic acid encapsulated with soluble soybean polysaccharide by spray-drying. Bioscience Biotechnology and Biochemistry, 66 (9): 1829-1834.
23. Montales, M.T.E., Rahal, O.M., Kang, J., Rogers, T.J., Prior, R.L., Wu, X., and, Simmen, R.C. 2012. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis, 33: 652-660.
24. Kerckhoffs, D.A., Brouns, F., Hornstra, G., and, Mensink, R.P. 2002. Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic, and tocotrienols. Journal of Nutrition, 132 (9): 2494-2505.
25. Takahashi, R., Ohmori, R., Kiyose, C., Momiyama, Y., Ohsuzu, F., and, Kondo, K. 2005. Antioxidant activities of black and yellow soybeans against low density lipoprotein oxidation. Journal of Agriculture and Food Chemistry, 53: 4578-4582.
26. Barnes, S., Boerma, B., Patel, R., Kirk, M., Darley-Usmer, G.S., Kim, H., and, Zu, J. 2000. Isoflavonoids and chronic disease: Mechanisms of action. Biofactors, 12: 209-215.
27. Soy, Jian, L. 2009. isoflavones, and prostate cancer. Molecular Nutrition and Food Research, 53 (2): 217-226.
28. Park, O.J., and, Surh, Y.J. 2004. Chemopreventive potential of epigallocatechin gallate and genistein: Evidence from epidemiological and laboratory studies. Toxicology Letters, 150: 43-56.
29. Qin, L.Q., Xu, J.Y., Wang, P.Y., and, Hoshi, K. 2006. Soyfood intake in the prevention of breast cancer risk in women: A meta-analysis of observational epidemiological studies. Journal of Nutrition Science and Vitaminology, 52: 428-436.
30. Tin, M.M.Y., Cho, C.H., Anthony, K.C., James, A.E., and, Joshua, K.S.K. 2007. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis, 28: 1347-1355.
31. Birt, D.F., Hendrich, S., and, Wang, W. 2001. Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacology and Therapeutics, 90 (23): 157-177.
32. Keinan-Boker, L., Van Der Schouw, Y.T., Grobbee, D.E., and, Peeters, P.H. 2004. Dietary phytoestrogens and breast cancer risk. American Journal of Clinical Nutrition, 79: 282-288.
33. Magee, P.J., McGlynn, H., and, Rowl, I.R. 2004. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Letters, 208 (1): 35-41.
34. Li, H.Q., Luo, Y., and, Qiao, C.H. 2012. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone. Mini-Reviews in Medical Chemistry, 12: 350-362.
35. Barnes, S. 1995. Genistein suppresses mammary cancer in rats. Carcinogenesis, 16: 2833-2840.
36. Lamartiniere, C.A., Moore, J.B., Brown, N.M., Thompson, R., Hardin, M.J., and, Barnes, S. 1995. Genistein suppresses mammary cancer in rats. Carcinogenesis, 16: 2833-2840.
37. Day, A.J., DuPont, M.S., Ridley, S., Rhodes, M., Rhodes, M.J., and, Morgan, M.R. 1998. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Letters, 436: 71-75.
38. Sfakianos, J., Coward, L., Kirk, M., and, Barnes, S. 1997. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. Journal of Nutrition, 127: 1260-1268.
39. Adlercreutz, H., Markkanen, H., and, Watanabe, S. 1993. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 342: 1209-1210.
40. Zhang, R., Barnes, S., and, Diasio, R.B. 1991. Absorption, metabolism, and tissue distribution of 2-fluoro-β-alanine conjugates of bile acids in the rat. Biochimica et Biophysica Acta, 1096: 179-186.
41. Xu, X., Harris, K.S., Wang, H.J., Murphy, P.A., and, Hendrich, S. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. Journal of Nutrition, 125: 2307-2315.
42. Rafii, F., Davis, C., Park, M., Heinze, T.M., and, Beger, R.D. 2003. Variations in metabolism of the soy isoflavonoid diadzein by human intestinal microfloras from different individuals. Archive Microbiology, 180 (1): 11-16.
43. Mcbain, A.J., and, Macfarlane, G.T. 1998. Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. Journal of Medical Microbiology, 47: 407-416.
44. Hur, H.G., Beger, R.D., Heinze, T.M., Lay, J.O., Freeman, J.P., Dore, J., and, Raffi, F. 2002. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid diadzein. Archive Microbiology, 178 (1): 8-12.
45. Winter, J., and, Moore, L.H. 1989. Dowell, Jr. V.R.; Bokkenheuser, V.D. C-ring cleavage of flavonoids by human intestinal bacteria. Applied Environmental Microbiology, 55: 1203-1208.
46. Supko, J.G., and, Malspeis, L. 1995. Plasma pharmacokinetics of genistein in 131 mice. International Journal of Oncology, 7: 847-854.
47. Ye, L., Chan, M.Y., and, Leung, L.K. 2009. The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Molecular and Cellular Endocrinology, 302: 73-80.
48. Kostelac, D., Rechkemmer, G., and, Briviba, K. 2003. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. Journal of Agriculture and Food Chemistry, 51: 7632-7635.
49. Miksicek, R.J. Estrogenic flavonoids: Structural requirements for biological activity. Proceedings of the Society for Experimental Biology and Medicine 1995, 208 (1) 44-50.
50. Giles, K., and, Wei, H. 1997. Effect of structurally related flavones/isoflavones on hydrogen peroxide production and oxidative DNA damage in phorbol ester-stimulated HL-60 cells. Nutrition Cancer, 29: 77-82.
51. Sierens, J., Hartley, J.A., Campbell, M.J., Leathem, A.J., and, Woodside, J.V. 2001. Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. Mutation Research, 485: 169-176.
52. Robak, J., and, Gryglewski, R.J. 1988. Flavonoids are scavengers of superoxide anion. Biochemical Pharmacology, 37: 83-88.
53. Husain, S.R., Cillard, J., and, Cillard, P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry. 1987, 26 2489-2491.
54. Shahidi, F., Janitha, P.K., and, Wanasundara, P.D. 1992. Phenolic antioxidants. Critical Reviews in Food Science and Nutrition, 32: 67-103.
55. Wei, H.W.L., Frenkel, K., Bowen, R., and, Barnes, S. 1993. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutrition Cancer, 20: 1-12.
56. Lee, H.P., Gourley, L., Duffey, S.W., Esteve, J., Lee, J., and, Day, N.E. 1991. Dietary effects on breast cancer risk in Singapore. Lancet, 337: 1197-1200.
57. Tuyns, A.J., Kaaks, R., and, Haelterman, M. 1988. Colorectal cancer and the consumption of foods: A case-control study in Belgium. Nutrition Cancer, 2: 189-204.
58. Kandaswami, C., Perkins, E., Soloniuk, D.S., Drzewiecki, G., and, Middleton, E.J. 1991. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Letters, 56: 147-152.
59. Dewick, P.M. 1988. " Isoflavonoids. In: The Flavonoids ". In Advances in Research Since 1980, Edited by: Harborne, J.B. 125-209. London: Chapman and Hall.
60. Steiner, C., Arnould, S., Scalbert, A., and, Manach, C. 2008. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. British Journal of Nutrition, 99: 78-108.
61. Le Bail, J.C., Varnat, F., Nicolas, J.C., and, Habrioux, G. 1998. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Letters, 130: 209-216.
62. Traganos, F., Ardelt, B., Halko, N., Bruno, S., and, Darzynkiewicz, Z. 1992. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Research, 52: 6200-6208.
63. Booth, C., Hargreaves, D.F., Hadfield, J.A., McGown, A.T, and, Potton, C.S. 1999. Isoflavones inhibits intestinal epithelial cell proliferation and induce apoptosis in vitro. British Journal of Cancer, 80: 1550-1557.
64. Matsukawa, Y., Marui, N., Sakai, T., Satomi, Y., Yoshida, M., Matsumoto, K., Nishino, H., and, Aoike, A. 1993. Genistein arrests cell cycle progression at G2-M. Cancer Research, 53: 1328-1331.
65. Zhou, J.R., Mukherjee, P., Gugger, E.T., Tanaka, T., Blackburn, G.L., and, Clinton, S.K. 1998. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Research, 58: 5231-5238.
66. Kyle, E., Neckers, L., Takimoto, C., Curt, G., and, Bergan, R. 1997. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Molecular Pharmocology, 51: 193-200.
67. Spinozzi, F., Pagliacci, M.C., Miglioati, G., Moraca, R., Grignani, F., Riccardi, C., and, Nicoletti, I. 1994. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jukat T-leukemia cells. Leukemia Research, 18: 431-439.
68. Murrill, W.B., Brown, N.M., Manzolillo, P.A., Zhang, J.X., Barnes, S., and, Lamartiniere, C.A. 1996. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis, 17: 1451-1457.
69. Pan, M.H., and, Ho, C.T. 2008. Chemopreventive effects of natural dietary compounds on cancer development. Chemical Society Reviews, 37: 2558-2574.
70. Talalay, P. 1989. Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Advance Enzyme Regulation, 28: 237-250.
71. Talalay, P., Fahey, J.W., Holtzclaw, W.D., Prestera, T., and, Zhang, Y. 1995. " Chemoprotection against cancer by phase 2 enzyme induction ". In Toxicology Letters 173-179. 82-83
72. Surh, Y.J., Chun, K.S., Chan, H.H., Han, S.S., Keum, Y.S., Park, K.K., and, Lee, S.S. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NFkB activation. Mutation Research, 480: 243-268.
73. Li, X., and, Stark, G.R. 2002. NFkB-dependent signaling pathways. Experimental Hematology, 30: 285-296.
74. Jun, H.S., Kim, S.E., and, Sung, M.K. 2002. Protective effect of soybean saponins and major antioxidants against aflatoxin B1-induced mutagenicity and DNA-adduct formation. Journal of Medicinal Food, 5: 235-240.
75. Djuric, Z., Chen, G., Doerge, D.R., Heilbrun, L.K., and, Kuckuk, O. 2001. Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Letters, 172: 1-6.
76. Mitchell, J.H., and, Collins, A.R. 1999. Effects of a soy milk supplement on plasma cholesterol levels and oxidative DNA damage in men. Europeon Journal of Nutrition, 38: 143-148.
77. McMichael-Phillips, D.F., Harding, C., Morton, M., Roberts, S.A., Howell, A., Potten, C.S., and, Bundred, N.J. 1998. Effects of soy protein supplementation on epithelial proliferation in the histologically normal human breast. Americian Journal of Clinical Nutrition, 68: 1431-1435.
78. Wakai, K., Ohno, Y., Genka, K., Ohmine, K., Kawamura, T., Tamakoshi, A., Lin, Y., Nakayama, T., Aoki, K., and, Fukuma, S. 1999. Risk modification in lung cancer by a dietary intake of preserved foods and soy foods: Findings from a case-control study in Okinawa, Japan. Lung Cancer, 25: 147-159.
79. Sakauchi, F., Khan, M.M., Mori, M., Kubo, T., Fujino, Y., Suzuki, S., and, Tokudome, S. 2007. Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutrition Cancer, 57: 138-145.
80. Yan, L. 2005. Meta-analysis of soy food and risk of prostate cancer in men. International Journal of Cancer, 117: 667-669.
81. Linassier, C., Pierre, M., Lepecq, J.B., and, Pierre, J. 1990. Mechanisms of action in NIH-3T3 cells of genislein. an inhibitor of EGF receptor tyrosine kinase activity. Biochemical Pharmacology, 39: 187-193.
82. Philp, E.A., and, Reed, M.W. 1996. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. British Journal of Eurology, 77: 352-357.
83. Okura, A.A.H., Oka, H., Yoshinari, T., and, Monden, Y. 1988. Effect of genistein on topoisomerase activity and on the growth of [VAL 121 Ha-ras-transformed NHI-3T3 cells. Biochemican and Biophysical Research Communications, 157: 183-189.
84. Pereira, M.A., Barnes, L.H., Rassman, V.L., Kelloff, G.L., and, Steele, V.E. 1994. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15: 1049-1054.
85. Steele, V.E., Pereira, M.A.,.Sigman, C.C., and, Kelloff, G.J. 1995. Cancer chemo preventive agent development strategies for genistein. Journal of Nutrition, 125: 713-716.
86. Chen, Y.R., Hsu, M.L., Ho, C.K., and, Wang, S.Y. 1993. Cell source and biological characteristics of murine bone marrow-derived colony-promoting activity. Experimental Hematology, 21 (9): 1219-1226.
87. Wang, S.Y., Su, C.Y., Hsu, M.L., Chen, L.Y., Tzeng, C.H., and, Ho, C.K. 1991. Effect of lipopolysaccharide on the production of colony-stimulating factors by the stromal cells in long-term bone marrow culture. Experimental Hematology, 19 (2): 122-127.
88. Liao, F.H., Chen, Y.J., and, Yang, Y.C. 2005. A novel polysaccharide of black soybean promotes myelopoiesis and reconstitutes bone marrow after 5-flurouracil-and irradiation-induced myelosuppression. Life Sciences, 77: 400-413.
89. Anthony, M.S., Clarkson, T.B., and, Williams, J.K. 1998. Effects of soy isoflavones on atherosclerosis: potential mechanisms. American Journal of Clinical Nutrition, 68: 1390-1397.
90. He, J., Gu, D., and, Wu, X. 2005. Effect of soybean protein on blood pressure: A randomized, controlled trial. Annals of International Medicine, 143: 1-9.
91. Washburn, S.G., Burke, L., Morgan, T., and, Anthony, M. 1999. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause, 6: 7-13.
92. Wilson, T.A., Nicolosi, R.J., Kotyla, T., and, Fleckinger, B. 2007. Soy protein without isoflavones reduces aortic total and cholesterol ester concentrations greater than soy protein with isoflavones compared with casein in hypercholesterolemic hamsters. Nutrition Research, 27: 498-504.
93. Sugano, M., and, Koba, K. 1993. Dietary protein and lipid metabolism: a multifunctional effect. Annals of the New York Academy of Sciences, 676: 215-222.
94. Baum, J.A., Teng, H., Erdman, J.W., Weigel, R.M., Klein, B.P., Persky, V.W., Freels, S., Surua, P., Bakit, R.M., Ramos, E., Shay, N.F., and, Potter, S.M. 1998. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American Journal of Clinical Nutrition, 68: 545-551.
95. Wong, J.M.W., Kendall, C.W.C., De Souza, R., Emam, A., Marchie, A., Vidgen, E., Holmes, C., and, Jenkins, D.J.A. 2010. The effect on the blood lipid profile of soy foods combined with a prebiotic: A randomized controlled trial. Metabolism, 59 (9): 1331-1340.
96. Jenkins, D.J., Kendall, C.W., Vidgen, E., Vuksan, V., Jackson, C.J., Augustin, L. S., Lee, B., Garsetti, M., Agarwal, S., Rao, A.V., Cagampang, G.B., and, Fulgoni, V. 2000. Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism, 49: 1496-1500.
97. Beynen, A.C. 1990. Comparison of the mechanism proposed to explain the hypocholesterolemic effect of soybean protein versus casein in experimental animals. Journal of Nutrition Science and Vitomology, 36: 87-97.
98. Kim, D.N., Lee, K.T., Reiner, J.M., and, Thomas, W.A. 1980. Increased steroid excretion in swine fed high-fat, high-cholesterol diet with soy protein. Experimenal Molecular Pathology, 33: 25-35.
99. Tanaka, K., Aso, B., and, Sugano, M. 1984. Biliary steroid excretion in rats fed soybean protein and casein or their amino acid mixtures. Journal of Nutrition, 114: 26-32.
100. Fumagalli, R., Soleri, L., Farini, R., Musanti, R., Marner, A.O., Noseda, G., Gatti, E., and, Sirtori, C.R. 1982. Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with soybean protein diet. Atherosclerosis, 43: 341-353.
101. Jaskiewicz, K., Weight, M.J., Christopher, K.J., Benade, A.J.S., and, Kritchevsky, D. 1987. A comparison of the effects of soyabean protein and casein on bile composition, cholelithiasis and serum lipoprotein lipids in the vervet monkey (Ceicopithecus aethiops). British Journal of Nutrition, 58: 257-263.
102. Iwami, K., Sakakibara, K., and, Ibuki, F. 1986. Involvement of post-digestion hydrophobic peptides in plasma cholesterol-lowering effect of dietary plant proteins. Agricultural and Biological Chemistry, 50: 1217-1222.
103. Nagaoka, S., Awano, T., Nagata, N., Masaoka, M., Hori, G., and, Hashimoto, K. 1997. Serum cholesterol reduction and cholesterol absorption inhibition in Caco-2 cells by a soy protein peptic hydrolysate. Bioscience Biotechnology and Biochemistry, 61: 354-356.
104. Nagata, Y., Ishiwaki, N., and, Sugano, M. 1982. Studies on the mechanism of the antihypercholesterolemia action of soy protein and soy protein-type amino acid mixtures in relation to their casein counterparts in rats. Journal of Nutrition, 112: 1614-1625.
105. Lovati, M.R., Manzoni, C., Canavesi, A., Sirtori, M., Vaccarino, V., Marchi, M., Caddi, G., and, Sirtori, C.R. 1987. Soybean protein diet increases low density lipoprotein.receptor activity in mononuclear cells from hypercholesterolemic patients. Journal of Clinical Investigation, 80: 1498-1502.
106. Lovati, M.R., Manzoni, C., Corsini, A., Granata, A., Frattini, R., Fumagalli, R., and, Sirtori, C.R. 1992. Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. Journal of Nutrition, 122: 1971-1978.
107. Sugano, M., Tanaka, K., and, Ide, T. 1982. Reduction of cholesterol, triglyceride, and apolipoprotein A-I by isolated perfused liver from rats fed soybean protein and casein or their amino acid mixtures. Journal of Nutriton, 112: 855-862.
108. Borradaile, M.N., De Dreu, L.E., Wilcox, L.J., Edwards, J.Y., and, Huff, M.W. 2002. Soya phytoestrogens, genistein and diadzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Journal of Biochemistry, 366: 531-539.
109. Barth, C.A., Scholz-Ahrens, K.E., Pfeuffer, M., and, Hotze, A. 1990. Response of hormones and lipid metabolism to different dietary proteins. Monographs on Atherosclerosis, 16: 212-215.
110. Scholz-Ahrens, K.E., Hagemeister, H., Unshelm, J., Agergaard, N., and, Earth, C.A. 1990. Response of hormones modulating plasma cholesterol to dietary casein or soy protein in minipigs. Journal of Nutrition, 120: 1387-1392.
111. Forsythe, W.A. 1990. Dietary protein, cholesterol, and thyroxine: A proposed mechanism. Journal of Nutrition Science and Vitaminology, 36: 595-598.
112. Ham, J.O., Chapman, K.M., Essex-Sorlie, D., Bakhit, R.M., Prabhudesai, M., Winter, L., Erdman, J.W., and, Potter, S.M. 1993. Endocrinological response to soy protein and fiber in mildly hypercholesterolemic men. Nutrtion Research, 13: 873-884.
113. Forsythe, W.A. 1995. Soy protein, thyroid regulation, and cholesterol metabolism. Journal of Nutrition, 125: 619-623.
114. Gown, A.M., Tsukada, T., and, Ross, R. 1986. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. American Journal of Pathology, 125: 191-207.
115. Woolf, N. 1999. Pathology of atherosclerosis, 533-539. Hodder and Stoughton Publishers: London.
116. Guyton, J.R., and, Klemp, K.F. 1989. The lipid-rich core region of human atherosclerotic fibrous plaques. Prevalence of small lipid droplets and vesicles by electron microscopy. American Journal of Pathology, 134: 705-717.
117. Small, D.M., and, Lyman, George. 1988. Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis, 8: 103-129.
118. Cassidy, A. 1999. Potential tissue selectivity of dietary phytoestrogens and estrogens. Current Opinion in Lipidology, 10: 47-52.
119. Helisten, H., Höckerstedt, A., Wahala, K., Tiitinen, A., Adlercreutz, H., and, Jauhiainen, M. 2001. M.J. Accumulation of high-density lipoprotein derived estradiol-17h fatty acid esters in low-density lipoprotein particles. Journal of Clinical Endocrinology and Metabolism, 86: 1294-1300. Tikkanen
120. Meng, Q.H., Hockerstedt, A., Heinonen, S., Wahala, K., Adlercreutz, H., and, Tikkanen, M.J. 1999. Antioxidant protection of lipoproteins containing estrogens: in vitro evidence for low-and high-density lipoproteins as estrogen carriers. Biochimica et Biophysica Acta, 1439: 331-340.
121. Rifici, V.A., and, Khachadurian, A.K. 1994. Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis, 107: 99-108.
122. Rice-Evans, C.A., Miller, N.J., and, Paganga, G. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine, 20: 933-956.
123. Ruiz-Larrea, M.B., Hohan, A.R., Paganga, G., Miller, N., Bolwell, G.P., and, Rice-Evans, C.A. 1997. Antioxidant activity of phytoestrogenic isoflavones. Free Radical Research, 26: 63-70.
124. Shimokado, K., Umezawa, K., and, Ogata, J. 1995. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Experimental Cell Research, 220: 266-273.
125. Kaamanen, M., Adlercreutz, H., Jauhiainen, M., and, Tikkanen, M.J. 2003. Accumulation of genistein and lipophilic genistein derivatives in lipoproteins during incubation with human plasma in vitro. Biochimica Biophysica Acta, 1631: 147-152.
126. Kuruvilla, A., Putcha, G., Poulos, E., and, Shearer, W.T. 1993. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line. Journal of Immunology, 151: 637-648.
127. Murphy, C.T., Kellie, S., and, Westwick, J. 1993. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses. European Journal of Biochemistry, 216: 639-651.
128. Asahi, M., Yanagi, S., and, Ohta, S. 1992. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. FEBS Letters, 309: 10-14.
129. Helmeste, D.M., and, Tang, S.W. 1995. Tyrosine kinase inhibitors regulate serotonin uptake in platelets. European Jouranal of Pharmocology, 280: 5-7.
130. Hirsh, A.J., Yao, S.Y., Young, J.D., and, Cheeseman, C.I. 1997. Inhibition of glucose absorption in the rat jejunum: A novel action of alpha-D glucosidase inhibitors. Gastroenterology, 113: 205-211.
131. Jenkins, D.J., Taylor, R.H., Goff, D.V., Fielden, H., Misiewicz, J.J., Sarson, D.L., Bloom, S.R., and, Alberti, K.G. 1981. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes, 30: 951-954.
132. Lee, S.D., and, Lee, S.H. 2001. Genistein, a soy iso£avone, is a potent -glucosidase inhibitor. FEBS Letters, 501: 84-86.
133. Vendavanam, K., Srijayanta, S.O., Reilly, J., Raman, A., and, Wiseman, H. 1999. Antioxidant action and potential antidiabetic properties of isoflavonoid-containing soybean phytochemical extract (SPE). Phytotherapy Research, 13: 601-608.
134. Liu, D., Zhen, W., Yang, Z., Carter, J.G., Si, H., and, Reynolds, K.A. 2006. Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes, 55: 1043-1050.
135. Sorenson, R., Brelje, C.T., and, Roth, C. 1994. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology, 4: 1975-1978.
136. Lavigne, C., Marette, A., and, Jacques, H. 2000. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. American Journal of Physiology Endocrinology and Metabolism, 278: 491-500.
137. Gannon, M.C., Nuttall, J.A., and, Nuttall, F.Q. 2002. The metabolic response to ingested glycine. American Journal of Clinical Nutrition, 76: 1302-1307.
138. Kahn, C.R., and, White, M.F. 1988. The insulin receptor and the molecular mechanism of insulin action. Journal of Clinical Investigation, 82: 1151-1156.
139. Olefsky, J.M. 1990. The insulin receptor. A multifunctional protein. Diabetes, 39: 1009-1016.
140. Chandalia, M., Garg, A., Lutjohann, D., Von Bergmann, K., Grundy, S.M., and, Brinkley, L.J. 2000. Beneficial effects of high dietary fiber intake in patients with type 2 Diabetes Mellitus. National England Journal of Medicine, 342: 1392-1398.
141. Jenkins, D.J.A., Kendall, C.W.C., and, Type, Aycols, M. 2003. 2 diabetes and vegetarian diet. American Journal of Clinical Nutrition, 78: 610-616.
142. Rubio, M.A. 2002. Implicaciones de la fibra en distintas patologias. Nutrition Hospital, 127: 17-29.
143. Jang, H.E., Ko, J.H., Ahn, C.W., Lee, H.H., Shin, J.K., Chang, S.J., Park, C.S., and, Kang, J.H. 2010. In vivo and in vitro application of black soybean peptides in the amelioration of endoplasmic reticulum stress and improvement of insulin resistance. Life Sciences, 86: 267-274.
144. Kwon, D.Y., Daily, J.W., Kim, H.J., and, Par, S. 2010. Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutrition Research, 30 (1): 1-13.
145. De Arruda Oliveira, E., Cheim, L.M.G., De Barros Reis, M.A., Carneiro, E.M., Boschero, A.C., and, Latorraca, M.Q. 2008. Nutritional recovery with a soybean flour diet improves the insulin response to a glucose load without modifying glucose homeostasis. Nutrition, 24: 76-83.
146. Gallagher, E., Kunkel, A., Gormley, T.R., and, Arendt, E.K. 2003. The effect of dairy and rice powder addition on loaf and crumb characteristics, and on shelf life (intermediate and long-term) of gluten-free breads stored in a modified atmosphere. European Food Research and Technology, 218: 44-48.
147. Marco, C., and, Rosell, C.M. 2008. Effect of different protein isolates and transglutaminase on rice. Our properties. Journal of Food Engineering, 84: 132-139.
148. Moore, M.M., Heinbockel, M., Dockery, P., Ulmer, H.M., and, Arendt, E.K. 2006. Network formation in gluten-free bread with application of transglutaminase. Cereal Chemistry, 83 (1): 28-36.
149. Ribotta, P.D., Ausar, S.F., Morcillo, M.H., Perez, G.T., Beltramo, D.M., and, Leon, A.E. 2004. Production of gluten-free bread using soybean flour. Journal of Science Food and Agriculture, 84: 1969-1974.
150. Brzezinski, A., Adlercreutz, H., Shaoul, R., Rosler, A., Shmueli, A., Tanos, V., and, Schenker, J.G. 1997. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause, 4: 89-94.
151. Witteman, J.C.M., Grobbee, D.E., Kok, F.J., Hofman, A., and, Valkenburg, H.A. 1989. Increased risk of atherosclerosis in women after the menopause. British Medical Journal, 298: 642-644.
152. Mousavi, Y.A.H. 1993. Genistein is an effective stimulator of sex hormonebinding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids, 58 (7): 301-304.
153. Ren, H., Liu, H., Endo, H., Takagi, Y., and, Hayashi, T. 2006. Antimutagenic and anti-oxidative activities found in Chinese traditional soybean fermented products furu. Food Chemistry, 95: 71-76.
154. Cos, P., De Bruyne, T., Apers, S., Vanden, T.B., Pieters, L., and, Vlietinck, A.J. 2003. Phytoestrogens: Recent developments. Planta Medicine, 69 (7): 589-599.
155. Adlercreutz, H., Hamalainen, E., Gorbach, S., and, Goldin, B. 1992. Dietary phyto-oestrogens and the menopause in Japan. Lancet, 339: 1233-1235.
156. Moller, J.F., Zierau, O., Hertrampf, T., Bliedtner, A., Diel, P., and, Vollmer, G. 2009. Long-term effects of dietary isoflavones on uterine gene expression profiles. Journal of Steroid Biochemistry and Molecular Biology, 113: 296-303.
157. Welty, F.K., Lee, K.S., Lew, N.S., and, Zhou, J.R. 2007. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Archives of International Medicine, 167: 1060-1067.
158. Jayagopal, V., Albertazzi, P., Kilpatrick, S.E., Howarth, M.E., Jennings, E.P., Hepburn, A.D., and, Atkin, L.S. 2002. Beneficial effects of soy phytoestrogens intake in postmenopausal women with type 2 diabetes. Diabetes Care, 25: 1709-1714.
159. Madar, Z. 1983. Effect of brown rice and soybean dietary fiber on the control of glucose and lipid metabolism in diabetic rats. American Journal of Clinical Nutrition, 38: 383-393.
160. Peng, S., Xia, R., Fang, H., Li, F., and, Chen, A. 2008. Effect of Epimedium-derived phytoestrogen on bone turnover and bone microarchitecture in OVX-induced osteoporotic rats. Journal of Huazhong University of Science and Technology, 28 (2): 167-170.
161. Ma, D.F., Qin, L.Q., Wang, P.Y., and, Katoh, R. 2008. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: Meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition, 62: 155-161.
162. Alekel, D.L., Germain, A.S., Peterson, C.T., Hanson, K.B.J., Stewart, W., and, Toda, T. 2000. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. American Journal of Clinical Nutrition, 72: 844-852.
163. Somekawa, Y., Chiguchi, M., Ishibashi, T., and, Aso, T. 2001. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology, 97: 109-115.
164. Szkudelska, K., and, Genistein, Nogowski, L. 2007. A dietary compound inducing hormonal and metabolic changes. Journal of Steroid Biochemistry and Molecular Biology, 105: 37-45.
165. Aoyama, T., Fukui, K., Takamatsu, K., Hashimoto, Y., and, Yamamoto, T. 2000. Soy protein isolate and its hydrolysates reduce body fat of dietary obese rats and genetically obese mice. Journal of Nutrition, 16: 1349-1354.
166. Naaz, A., Yellayi, S., Zakroczymski, M.A., Bunick, D., Doerge, D.R., and, Lubahn, D.B. 2003. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology, 144: 3315-3320.
167. Guo, Y., Wu, G., Su, X., Yang, H., and, Zhang, J. 2009. Antiobesity action of a diadzein derivative on male obese mice induced by a high-fat diet. Nutrition Research, 29: 656-663.
168. Perry, V.H., Bell, M.D., Brown, H.C., and, Matyszak, M.K. 1995. Inflammation in the nervous system. Current Opinion in Neurobiology, 5: 636-641.
169. McGeer, P.L., and, McGeer, E.G. 2004. Inflammation and the degenerative diseases of aging. Annals of NewYork Academy of Sciences, 1035: 104-116.
170. Sonee, M., Sum, T., Wang, C., and, Mukherjee, S.K. 2004. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurology and Toxicology, 25: 885-891.
171. Trieu, V.N., and, Uckun, F.M. 1999. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochemical and Biophysical Research Communications, 258: 685-688.
172. Wang, X., Chen, S., Ma, G., Ye, M., and, Lu, G. 2005. Genistein protects dopaminergic neurons by inhibiting microglial activation. Neuroreport, 16: 267-270.
173. Trieu, V.N., Dong, Y., Zheng, Y., and, Uckun, F.M. 1999. In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke. Radiation Research, 152: 508-516.
174. Linford, N.J., and, Dorsa, D.M. 2002. 17β-Estradiol and the phytoestrogen attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium ATPase inhibitor thapsigargin. Steroids, 67: 1029-1040.
175. Gottstein, N., Ewins, B.A., Eccleston, C., Hubbard, G.P., Kavanagh, I.C., Minihane, A.M., Weinberg, P.D., and, Rimbach, G. 2003. Effect of genistein and diadzein on platelet aggregation and monocyte and endothelial function. British Journal of Nutrition, 89: 607-615.
176. Avdi, N.J., Malcolm, K.C., Nick, J.A., and, Worthen, G.S. 2002. A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH (2)-terminal kinase pathway in human neutrophils. Journal of Biology and Chemistry, 277 (43): 40687-40697.
177. Stantchev, T.S., Markovic, I., Telford, W.G., Clouse, K.A., and, Broder, C.C. 2007. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Research, 123: 178-189.
178. Ji, G., Qi, R., Wang, H., Feng, C., and, Leng, J. 2010. A planting and eating soybean project for people living with HIV/AIDS in rural Anhui-A pilot study in China. Journal of AIDS. Care, 22 (1): 126-132.
179. Cheng, C., Wang, X., Weakley, S.M., Kougias, P., Lin, P.H., Yao, Q., and, Chen, C. 2010. The soybean isoflavonoid equol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. Journal of Nutrition, 140 (1): 12-17.
180. Chow, J.M. 2002. Probiotics and prebiotics: A brief overview. Journal of Renal Nutrition, 12: 76-86.
181. Cheng, I.C., Shang, H.F., Lin, T.F., Wang, T.H., and, Lin, H.S. 2005. Effect of fermented soy milk on the intestinal bacterial ecosystem. World Journal of Gastroenterology, 11 (8): 1225-1227.
182. Ding, L.A., and, Li, J.S. 2004. Intestinal failure: Pathophysiological elements and clinical diseases. World Journal of Gastroenterology, 10: 930-933.